< Back to search
Filter
1
Active & Responsive

GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy

for
Castration-resistant Prostate Cancer
Location: Richmond VA
Sponsor: Virginia Commonwealth University

Sex: Male

Age: 18+

Code: NCT06636123

Phase1, Recruiting
Active & Responsive

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

for
Localized Renal Pelvis and Ureter Urothelial Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: Male

Age: 18+

Code: NCT01050504

Recruiting
Active & Responsive

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

for
Castration-Resistant Prostate Cancer (CRPC),
Location: East Brunswick NJ, Omaha NE, West Valley City UT,
Sponsor: Monte Rosa Therapeutics, Inc

Sex: Male

Age: 18+

Code: NCT07745361

Phase2, Recruiting
Active & Responsive

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

for
Metastatic Castration Resistant Prostate Cancer, mCRPC,
Location: East Brunswick NJ, Fairfax VA, Myrtle Beach SC,
Sponsor: Flare Therapeutics Inc.

Sex: Male

Age: 18+

Code: NCT07719361

Phase1, Recruiting
Active & Responsive

Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

for
Reccurent/Metastatic Solid Tumor Disease,
Location: Quebec
Sponsor: CHU de Quebec-Universite Laval

Sex: Male

Age: 18+

Code: NCT07483658

Recruiting

Interested in new prostate cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

for
Castration Resistant Metastatic Prostate Cancer,
Location: Miami FL, Grand Rapids MI, Omaha NE, Irvine CA
Sponsor: Aktis Oncology, Inc.

Sex: Male

Age: 18+

Code: NCT07581184

Phase1, Recruiting
Active & Responsive

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

for
Castration-Resistant Prostate Cancer (CRPC), Colorectal Cancer,
Location: Dothan AL, Grand Rapids MI, Omaha NE
Sponsor: Radiopharm Theranostics, Ltd

Sex: All

Age: 18+

Code: NCT07189871

Phase1, Phase2, Recruiting
Active & Responsive

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

for
Prostate Cancer Patients Treated by Radiotherapy,
Location: Saddle Brook NJ, Towson MD, Myrtle Beach SC,
Sponsor: Candel Therapeutics, Inc.

Sex: Male

Age: 18+

Code: NCT07332000

Phase2, Recruiting
Active & Responsive

The Florida ASCENT Study

for
Cancer, Food Deprivation, Food Habits, Food Selection,
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 18 - 70+

Code: NCT07042243

Recruiting
Active & Responsive

Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC

for
Prostate Cancer Patients, Non-castrate Prostate Cancer,
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: Male

Age: 18+

Code: NCT07090148

Phase1, Recruiting
Active & Responsive

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

for
Prostate Cancer Castration-resistant Prostate Cancer,
Location: East Brunswick NJ, Fairfax VA, Grand Rapids MI,
Sponsor: MBrace Therapeutics

Sex: All

Age: 18+

Code: NCT07145255

Phase1, Phase2, Recruiting
Active & Responsive

Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer

for
Prostate Cancer
Location: New York NY
Sponsor: NYU Langone Health

Sex: Male

Age: 40 - 70+

Code: NCT07184957

Recruiting
Active & Responsive

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

for
Metastatic Castration-resistant Prostate Cancer
Location: Montreal, Miami FL, Dothan AL, Metairie LA, Omaha NE,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT07611110

Phase3, Recruiting
Active & Responsive

Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer

for
Prostate Cancer, Metastatic Prostate Cancer,
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: Male

Age: 21+

Code: NCT07032584

Recruiting
Active & Responsive

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

for
Triple Negative Breast Cancer, HER2-negative Breast Cancer,
Location: Fairfax VA, Orlando FL, Huntersville NC, Sarasota FL,
Sponsor: Dren Bio

Sex: All

Age: 18+

Code: NCT06999187

Phase1, Recruiting
Active & Responsive

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

for
Prostate Cancer,
Location: Myrtle Beach SC, Charlottesville VA, Tampa FL,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: Male

Age: 18+

Code: NCT07005154

Phase2, Recruiting
Active & Responsive

Customized TULSA-PRO Ablation Registry

for
Prostate Cancer, Prostate Adenocarcinoma,
Location: York PA, Jacksonville FL, Dallas TX, San Antonio TX,
Sponsor: Profound Medical Inc.

Sex: Male

Age: 18+

Code: NCT05001477

Recruiting
Active & Responsive

Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial

for
Prostate Cancer
Location: Boston MA, Clifton NJ, Austin TX
Sponsor: Palette Life Sciences, Inc.

Sex: Male

Age: 18+

Code: NCT06496256

Recruiting
Active & Responsive

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

for
Prostate Cancer, Prostatic Neoplasms
Location: Boston MA, New Haven CT, West Haven CT, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: Male

Age: 18+

Code: NCT06925737

Phase3, Recruiting
Active & Responsive

ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer

for
Prostate Cancer
Location: New York NY
Sponsor: NYU Langone Health

Sex: Male

Age: 18+

Code: NCT06397703

Phase2, Recruiting